Journal of Medicinal Chemistry p. 352 - 356 (1988)
Update date:2022-09-26
Topics: Chemical Synthesis Clinical Trials Regulatory Approval Pharmacokinetic Studies Toxicity and Safety Evaluation Biological Activity Testing Spectroscopic Characterization
Howson, W.
Kitteringham, J.
Mistry, J.
Mitchell, M. B.
Novelli, R.
et al.
6-<4-<3-<<2-Hydroxy-3-<4-<2-(cyclopropylmethoxy)ethyl>phenoxy>propyl>amino>propionamido>phenyl>-5-methyl-4,5-dihydro-3(2H)-pyridazinone (3) consists of a mixture of four stereoisomers, i.e., two racemates, as aconsequence of the two asymmetric centers con
View MoreContact:+86-13914766747
Address:Floors 21&22, Jin Cheng Tower, No. 216 Middle Longpan Road, Nanjing
Shanghai Puda Chemical Co.,Ltd
Contact:+86+571+56565965
Address:10F Haiyue Building,Danfeng Road,Binjiang District,Hangzhou,China
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Beyond Pharmaceutical Co., Ltd
Contact:+86-571-8195-3185
Address:No. 13-1, Liansheng Road, Yuhang District
Hangzhou Dingyan Chem Co., Ltd
website:http://www.dingyanchem.com
Contact:86-571-87157530
Address:RM.1118,NO.1 Building, Baiyun Tower,Jianggan Area, Hangzhou city, China,310004
Doi:10.1021/jo01074a027
(1960)Doi:10.1002/(SICI)1096-9063(199911)55:11<1116::AID-PS65>3.0.CO;2-Y
(1999)Doi:10.1016/j.tet.2008.10.109
(2009)Doi:10.1021/jo800950y
(2008)Doi:10.1021/ja710749q
(2008)Doi:10.1016/j.bmc.2015.08.005
(2015)
